CAPLIN POINT LABORATORIES
Back to All Ratios
|
CAPLIN POINT LABORATORIES Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PCE(x) | 15.83 | 25.07 | 19.43 | 10.73 | 14.50 |
What is the latest Price to Cash Earnings (PCE) ratio of CAPLIN POINT LABORATORIES ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2026 | 15.83 |
| Mar2025 | 25.07 |
| Mar2024 | 19.43 |
| Mar2023 | 10.73 |
| Mar2022 | 14.50 |
How is Price to Cash Earnings (PCE) of CAPLIN POINT LABORATORIES Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2026 | 15.83 | -36.86 | |
| Mar2025 | 25.07 | 29.03 | |
| Mar2024 | 19.43 | 81.08 | |
| Mar2023 | 10.73 | -26.00 | |
| Mar2022 | 14.5 | - | |
Other Financial Ratios of CAPLIN POINT LABORATORIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹18,151.8 Cr | 0.3% | 1.2% | 30.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 0.3% |
1.2% |
30.5% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses